Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients

Clinical trial NCT00467311 · COMPLETED

Trial details

NCT number: NCT00467311
Sponsor: National Heart Institute, Mexico
Status: COMPLETED
Study type: OBSERVATIONAL

Contrast Induced Nephropathy Acute Renal Failure

Start date: 2006-12-01
Primary completion: 2007-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.